Showing results (1-10 of 29) with videos related to
Sort By:
Pageof 3
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|October 7, 2024
Sickle Cell DiseaseJoachim B Kunz, Laura TagliaferriHemasphere|September 28, 2020
Gene Therapy of the HemoglobinopathiesJoachim B Kunz, Andreas E KulozikThe Journal of Biological Chemistry|December 18, 2003
Determination of four sequential stages during microautophagy in vitroJoachim B Kunz, Heinz Schwarz, Andreas MayerAnnals of Hematology|January 21, 2026
Case series: a rare dominant form of β-thalassemia successfully treated by luspaterceptPierre N Allard, Andreas E Kulozik, Joachim B KunzPediatric Blood & Cancer|April 7, 2017
The epidemiology of sickle cell disease in Germany following recent large-scale immigrationJoachim B Kunz, Holger Cario, Regine Grosse, et al.The EMBO Journal|February 8, 2008
Interactions between UPF1, eRFs, PABP and the exon junction complex suggest an integrated model for mammalian NMD pathwaysPavel V Ivanov, Niels H Gehring, Joachim B Kunz, et al.RNA (New York, N.Y.)|April 8, 2006
Functions of hUpf3a and hUpf3b in nonsense-mediated mRNA decay and translationJoachim B Kunz, Gabriele Neu-Yilik, Matthias W Hentze, et al.International Journal of Neonatal Screening|February 2, 2021
Introduction of Universal Newborn Screening for Sickle Cell Disease in Germany-A Brief Narrative ReviewStephan Lobitz, Joachim B Kunz, Holger Cario, et al.Journal of Pediatric Hematology/Oncology|October 26, 2021
Cui Bono? Identifying Patient Groups That May Benefit From Granulocyte Transfusions in Pediatric Hematology and OncologyPascal D Johann, Patrick Wuchter, Lenka Trojanova, et al.Molecular Cell|October 8, 2005
Exon-junction complex components specify distinct routes of nonsense-mediated mRNA decay with differential cofactor requirementsNiels H Gehring, Joachim B Kunz, Gabriele Neu-Yilik, et al.Pageof 3